Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Recruiting 6Not yet recruiting 1Enrolling by invitation 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 4NIH 2

Study Type

Observational 3Interventional 3

Sponsor

Cancer Type

Endocrine 5

Conditions

Breast Neoplasms 1215Neoplasms 1024Carcinoma, Non-Small-Cell Lung 747Prostatic Neoplasms 687Colorectal Neoplasms 590Lung Neoplasms 572Pancreatic Neoplasms 394Leukemia, Myeloid, Acute 394Neoplasm Metastasis 387Ovarian Neoplasms 370Multiple Myeloma 369Stomach Neoplasms 316Carcinoma, Hepatocellular 301Melanoma 281Brain Neoplasms 277Recurrence 273Squamous Cell Carcinoma of Head and Neck 267Head and Neck Neoplasms 237Endometrial Neoplasms 234Glioblastoma 233Triple Negative Breast Neoplasms 228Uterine Cervical Neoplasms 221Precursor Cell Lymphoblastic Leukemia-Lymphoma 221Lymphoma 221Sarcoma 201Hematologic Neoplasms 199Urinary Bladder Neoplasms 196Esophageal Neoplasms 190Carcinoma, Renal Cell 187Lymphoma, Non-Hodgkin 175

Interventions

Observation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Recruiting × Hyperaldosteronism × 1 year × Clear all
NCT03374215 2026-06-05

Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks

National Institutes of Health Clinical Center (CC)

Recruiting
1,150 enrolled
Endocrine

ACTH Syndrome, Ectopic, Adrenal Gland Neoplasms, Bone Diseases, Metabolic, Cardiovascular Diseases, Hyperaldosteronism, Hyperinsulinism, Hypertension

NCT05368090 2026-05-08

Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary Aldosteronism

Haukeland University Hospital

Phase NA Recruiting
60 enrolled
Endocrine

Cushing Syndrome, Hyperaldosteronism, Adrenocortical Adenoma

NCT00669266 2026-05-07

Adrenal Tumors - Pathogenesis and Therapy

University of Wuerzburg

Recruiting
500 enrolled
Endocrine

Adrenal Gland Neoplasms, Cushing Syndrome, Hyperaldosteronism, Pheochromocytoma, Adrenocortical Carcinoma

NCT06246357 2025-12-09

Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting
80 enrolled

Adenoma, Cushing Syndrome, Hyperaldosteronism

NCT07272187 2025-12-09

EURAGIL

Herlev Hospital

Recruiting
138 enrolled
Endocrine

Hyperaldosteronism, Insulinoma

NCT07027254 2025-06-18

PETAL Trial: Impact of Gallium-68 Pentixafor PET-CT on Surgical Outcomes in Primary Aldosteronism

Seoul National University Hospital

Phase NA Recruiting
90 enrolled
Endocrine

Hyperaldosteronism, Adrenocortical Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡